See All Slides - tctmd.com

Slides

Presentation TCT 2013

TCT-45. Use of drug-eluting stent (DES) with bioresorbable polymer in patients with ST-segment elevation myocardial infarction (STEMI) - Mid- and long-term clinical outcomes

Presenter: Andres I?iguez

October 29, 2013

Presentation TCT 2013

Essential TAVR Technique: From Patient Selection and Workup to Access Routes to Indispensable Tips and Trick

Presenter: Samir Kapadia

October 29, 2013

Presentation TCT 2013

Catheter Design and Cell Retention: Strategies to Optimization

Presenter: Jozef Bartunek

October 29, 2013

Presentation TCT 2013

Update on the Global Registry of Degenerative Bioprosthetic Valves

Presenter: Danny Dvir

October 29, 2013

Presentation TCT 2013

TCT-48. Comparison of long-term outcome between transradial approach and transfemoral approach for patients with ST-segment elevation myocardial infarction.

Presenter: Ryuma Ishihara

October 29, 2013

Presentation TCT 2013

Effective Antegrade Cardiac Gene Therapy with VEGF-B167 for Pacing-induced Dilated Cardiomyopathy in a Pre-clinical Large Animal Model of Heart Failure

Presenter: Felix Woitek

October 29, 2013

Presentation

The Minimalist Approach to TAVR: Ad Hoc and Single-Staged Procedures

Presenter: Fabian Nietlispach

October 29, 2013

Presentation TCT 2013

TAVI Karlsruhe (TAVIK) – a comparison of minimal invasive and surgical aortic valve replacement in patients with severe symptomatic aortic stenosis and intermediate risk for conventional surgery

Presenter: Gerhard Schymik

October 29, 2013

Presentation TCT 2013

TCT-113. Clinical and Left Ventricular Functional Outcomes Associated with Cardiac Biomarker Elevation after Transfemoral TAVR: A Sub-analysis from the PARTNER Trial

Presenter: Alan Zajarias

October 29, 2013

Presentation TCT 2013

SORT-OUT VI: A Prospective, Randomized, All-Comers Trial of Biodegradable Polymer-Coated Biolimus-Eluting Stents vs. Biocompatible Polymer-Coated Zotarolimus-Eluting Coronary...

Presenter: Bent Raungaard

October 29, 2013

Advertisement

Slides

TCT-45. Use of drug-eluting stent (DES) with bioresorbable polymer in patients with ST-segment elevation myocardial infarction (STEMI) - Mid- and long-term clinical outcomes

Essential TAVR Technique: From Patient Selection and Workup to Access Routes to Indispensable Tips and Trick

Catheter Design and Cell Retention: Strategies to Optimization

Update on the Global Registry of Degenerative Bioprosthetic Valves

TCT-48. Comparison of long-term outcome between transradial approach and transfemoral approach for patients with ST-segment elevation myocardial infarction.

Effective Antegrade Cardiac Gene Therapy with VEGF-B167 for Pacing-induced Dilated Cardiomyopathy in a Pre-clinical Large Animal Model of Heart Failure

The Minimalist Approach to TAVR: Ad Hoc and Single-Staged Procedures

TAVI Karlsruhe (TAVIK) – a comparison of minimal invasive and surgical aortic valve replacement in patients with severe symptomatic aortic stenosis and intermediate risk for conventional surgery

TCT-113. Clinical and Left Ventricular Functional Outcomes Associated with Cardiac Biomarker Elevation after Transfemoral TAVR: A Sub-analysis from the PARTNER Trial

SORT-OUT VI: A Prospective, Randomized, All-Comers Trial of Biodegradable Polymer-Coated Biolimus-Eluting Stents vs. Biocompatible Polymer-Coated Zotarolimus-Eluting Coronary...

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content